The use of agonistic anti-CD40 therapy in treatments for cancer
Agonistic anti-CD40 antibody is a potent stimulator of anti-tumor immune responses due to itsaction on both immuneand tumor cells. It has the ability to “precondition” dendritic cells, allowingthem to prime effective cytotoxic T-cell responses. Thus, anti-CD40 antibody provides an idealtherapy for c...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Taylor & Francis
2012
|
| Subjects: | |
| Online Access: | http://informahealthcare.com/loi/iri http://hdl.handle.net/20.500.11937/49580 |